Iktos
ApprovedIktos combines generative AI, retrosynthesis and robotics to accelerate small-molecule drug discovery from design to preclinical candidate, reducing timelines to under 24 months.
Founded
2016
Focus
AI / Machine Learning
About
Iktos combines generative AI, retrosynthesis and robotics to accelerate small-molecule drug discovery from design to preclinical candidate, reducing timelines to under 24 months.
Funding History
2Total raised: $19M
Series A$15.5MM VenturesOct 15, 2021
Seed$3.5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2016
LocationParis, France
StageApproved
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile